ビオフェルミン製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証1部 | 医薬品 | 4517/E00960 | BIOFERMIN PHARMACEUTICAL CO.,LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2016/06/03 | 日証協 | 23,090株 | -7.28% | 1,700株 | +19.38% | 27,955株 | -3.12% | 2,900株 | +44.93% |
| 2016/05/27 | 日証協 | 24,902株 | -9.12% | 1,424株 | -59.59% | 28,855株 | -3.99% | 2,001株 | -75.89% |
| 2016/05/20 | 日証協 | 27,402株 | -18.42% | 3,524株 | -80.64% | 30,054株 | +6% | 8,300株 | +653.86% |
| 2016/05/13 | 日証協 | 33,590株 | +50.7% | 18,200株 | +2933.33% | 28,354株 | +1.07% | 1,101株 | +57.29% |
| 2016/05/06 | 日証協 | 22,290株 | 0% | 600株 | +500% | 28,053株 | -4.43% | 700株 | +250% |
| 2016/04/28 | 日証協 | 22,290株 | -0.89% | 100株 | -85.71% | 29,353株 | -0.68% | 200株 | +100% |
| 2016/04/22 | 日証協 | 22,490株 | +7.1% | 700株 | -56.25% | 29,553株 | +2.78% | 100株 | -92.86% |
| 2016/04/15 | 日証協 | 21,000株 | -4.5% | 1,600株 | -74.6% | 28,753株 | -2.71% | 1,400株 | -75.44% |
| 2016/04/08 | 日証協 | 21,990株 | +25.01% | 6,300株 | -36.94% | 29,553株 | +17.5% | 5,700株 | -26.95% |
| 2016/04/01 | 日証協 | 17,590株 | +16.57% | 9,990株 | +51.36% | 25,152株 | +14.05% | 7,803株 | +143.84% |
| 2016/03/25 | 日証協 | 15,090株 | +27.99% | 6,600株 | +367.42% | 22,053株 | +11.64% | 3,200株 | +300% |
| 2016/03/18 | 日証協 | 11,790株 | -2.48% | 1,412株 | -38.93% | 19,753株 | -2.47% | 800株 | -61.9% |
| 2016/03/11 | 日証協 | 12,090株 | +1.68% | 2,312株 | -50.81% | 20,253株 | -5.59% | 2,100株 | -32.26% |
| 2016/03/04 | 日証協 | 11,890株 | +34.93% | 4,700株 | -6% | 21,453株 | +24.34% | 3,100株 | -43.64% |
| 2016/02/26 | 日証協 | 8,812株 | -24.7% | 5,000株 | +25.31% | 17,253株 | -17.26% | 5,500株 | +2650% |
| 2016/02/19 | 日証協 | 11,702株 | +2.63% | 3,990株 | +9999.99% | 20,853株 | 0% | 200株 | -87.53% |
| 2016/02/12 | 日証協 | 11,402株 | +11.76% | 28株 | -97.8% | 20,853株 | +5.6% | 1,604株 | -19.96% |
| 2016/02/05 | 日証協 | 10,202株 | +21.28% | 1,272株 | -32.7% | 19,748株 | 0% | 2,004株 | +186.29% |
| 2016/01/29 | 日証協 | 8,412株 | -16.73% | 1,890株 | +845% | 19,748株 | +3.67% | 700株 | -58.82% |
※株式分割は考慮していませんのでご注意ください。